Dementia is a costly condition and one that differs from other conditions in the significant cost burden placed on informal caregivers. The aim of this analysis was to estimate the economic and social costs of dementia in Ireland in 2010. With an estimate of 41,470 people with dementia, the total baseline annual cost was found to be over €1.69 billion, 48% of which was attributable to the opportunity cost of informal care provided by family and friends and 43% to residential care.
Research
DRNI Members Research is a list of ongoing and completed research carried out by DRNI members.
You can search via project type, disease, or Principal Investigator/Researcher name.
Search
Research type
Disease area
- Dementia (including Alzheimer's Disease and other dementias) (64)
- Parkinson's Disease and related disorders (16)
- Motor Neurone Disease (14)
- Neurodegenerative Disease (12)
- Lewy Body Dementia (2)
- Mild Cognitive Impairment (1)
- Not specified (1)
- Progressive Supranuclear Palsy and Corticobasal Syndrome (1)
- Young Onset Dementia (1)
Field of research
- Basic/Discovery Research (38)
- Clinical Research (27)
- Social Research (13)
- Public Health (6)
- Connected Health (5)
- Economic Research (4)
- Brain Health (3)
- Assistive technology for dementia (2)
- Clinical Research, Social Research, Connected Health, Economic Research (2)
- Health Services Research (2)
- Neurodegeneration (2)
- Social research, Economic research (2)
- Ageing and Nutrition research (1)
- Digital palliative care (1)
- Gait Speed and Technology (1)
- Nursing care (1)
- Occupational Therapy (1)
- Pharmacology & Therapeutics (1)
Project Aim(s): To discover new causative and disease-modifying pathways to pave the way for novel therapies.
Initial review work with non-participant observation of care to gather observer perspectives of pre-school age children engaging with older people with cognitive decline. Loosely informed by Hodges’ health career framework to include physical, psychological, social and organisational benefits.
Cognitive stimulation therapy (CST) is the only evidence-based intervention that improves cognition and quality of life for people with mild-moderate dementia. CST offers an ideal solution to the demand for early interventions for those with dementia in Ireland.
Genio is a non-profit organisation which aims to bring together government and private/ philanthropy funders to develop cost-effective ways of supporting people who are disadvantaged to live full lives in their communities. With funding from the Atlantic Philanthropies and the Health Service Executive (HSE) it has supported and facilitated considerable investment in dementia in Ireland. For example, in 2012 it supported four regional projects which aimed to develop and test new service models that would improve the range and quality of community-based supports for people with dementia.
Project Aim(s): This study aims to contribute to improving quality of life for people with end stage dementia living in residential care settings by investigating the experiences of elderly spouses whose relatives died with end-stage dementia in nursing homes in both Northern Ireland (NI) and the Republic of Ireland (RoI). A second aim is to develop guidelines for nursing home staff for the delivery of quality care in residents with end stage dementia in residential institutions.
Harnessing community information and support for people with young onset dementia and their families
Young onset dementia (YOD) varies in many respects to typical aged dementia. The person with YOD will live with an increasing number of cognitive, neurological, psychological, emotional, economic and social changes. There are about 4,000 people with YOD in Ireland. A recent Irish report on YOD (Fox, Cahill, McGowan, & Kilty, 2020) emphasised the urgent need for improved health services and community supports to provide comprehensive and individualised care for Irish people living with YOD.